Carrie Williams

Carrie (Hurwitz) Williams is a seasoned professional in the healthcare and pharmaceutical sectors, currently serving as Vice President and Partner at McKesson Ventures since September 2017. Prior experience includes roles as Vice President of Strategy & Business Development at Omada Health and various positions at McKesson, culminating as Senior Director of Corporate Strategy & Business Development. Initial experience includes management of clinical trials at Synta Pharmaceuticals, where responsibilities expanded into business development, and clinical trial operations at Wyeth for metastatic breast cancer programs. Carrie holds an MBA from the University of California, Berkeley, Haas School of Business, and a BS in Biology from the University of Massachusetts at Amherst.